Drug Profile
V-DOS 47
Alternative Names: V-DOS-47Latest Information Update: 13 Dec 2022
Price :
$50
*
At a glance
- Originator Helix BioPharma
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Immunotherapies; Ureases
- Mechanism of Action Cell death stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer